Price goug­ing on drugs? Shkre­li's ju­ry se­lec­tion process re­veals some deep pub­lic anger

If the US ever does pass laws pro­hibit­ing price goug­ing on drugs, phar­ma ex­ecs would be well ad­vised to avoid any test­ing of the bound­aries. There’s clear­ly a large seg­ment of the pub­lic that’s ready to jail any­one who jacks up the price of a des­per­ate­ly need­ed treat­ment.

Harp­er’s mag­a­zine helped il­lus­trate that point when they ran ex­cerpts from the com­ments made by po­ten­tial ju­rors in the Mar­tin Shkre­li case. Shkre­li is no­to­ri­ous for rais­ing the price of Dara­prim by more than 5000%, and some of the prospec­tive ju­rors were clear­ly ready to send him right be­hind bars — with­out any need for a tri­al.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER